Sio Gene Therapies

+$0.01 (+0.46%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SIOX and other ETFs, options, and stocks.

About SIOX

Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease.

CEO
Pavan Cheruvu
Employees
42
Headquarters
New York, New York
Founded
2014

SIOX Key Statistics

Market Cap
159.74M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
769.34K
High Today
$2.21
Low Today
$2.10
Open Price
$2.20
Volume
898.65K
52 Week High
$4.15
52 Week Low
$1.76

SIOX Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure